Please login to the form below

Not currently logged in
PMLiVE Top Pharma List


Revenue 2017


The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Eylea was produced by Bayer.

Regeneron’s Dupixent and Praluent fall short

Regeneron’s Dupixent and Praluent fall short

Regeneron’s chief executive Len Schleifer said on a conference call that global sales of Eylea were $1.6bn, with Regeneron booking $984m, up 15%. ... Nevertheless, Schleifer told analysts that Dupixent and the immuno-oncology pipeline in particular are

Shaping healthcare

Shaping healthcare Or with our other big growth product Eylea, a VEGF treatment for the retina, we have 80, 000 patients under treatment as we speak.

Pharma sales help Bayer escape the worst from a bumpy 2017

Pharma sales help Bayer escape the worst from a bumpy 2017 Together they brought in just over 6.5bn, although Xarelto and Eylea accounted for over 80% of the total. ... Among them were a 7, 000 patient study of Xarelto in secondary stroke, a combination trial of Eylea and a drug-device combination for pneumonia.

The good, the bad and the ugly

The good, the bad and the ugly Bayer’s growth - a healthy 14.6% - was stimulated by a steady performance by Xarelto in Europe and Asia, and strong sales of its eye medicine Eylea in Japan, Europe and ... Regeneron remains the leading player, with 10% growth in 2017 thanks to

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ()

Featured jobs

Subscribe to our email news alerts


Add my company

Transforming healthcare outsourcing. From small beginnings in 1997, Ashfield has grown rapidly into an international healthcare services organisation. By anticipating...

Latest intelligence

Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....
The rise of vertical integration in the US payer landscape
Is it a solution to addressing the challenges of the value-based marketplace?...
Creativity has lost its worth
Creativity has lost its worth, and sadly it is undermining effectiveness...